GrantQuick

health · HHS-CDC-NCHHSTP

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

Centers for Disease Control - NCHHSTP · CDC-RFA-PS-27-0009

Closed

Total Program Funding

$450.0M

Expected Awards

60

Deadline

TBD

GRANTQUICK SUMMARYPlain-English Overview

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP). Centers for Disease Control - NCHHSTP. This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and... $450,000,000 total program funding; ~60 awards expected.

Who Should Apply

Other eligible entities, State governments, Special district governments, City/township governments, County governments

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

  • Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings.

This multi-component NOFO includes two required components and two optional components:

  • Component 1: Outbreak Response and Surveillance (Required)
  • Component 2: Planning, Partnerships, and Promotion (Required)
  • Component 3: Testing, Treatment, and Prevention (Optional)
  • Component 4: Perinatal Hepatitis C Program (Optional)

This NOFO is alignment with CDC priorities. 

Who Can Apply

Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia. Local health agencies or their bona fide agents. If the city does not have a public health department, then the county covering the jurisdiction may apply (i.e., Los Angeles, CA covered by Los Angeles County and Phoenix, AZ covered by Maricopa County). All U.S. territories Bona fide agents must submit documentation that demonstrates their arrangement with the eligible applicant.

Eligible Applicant Types

City/Township GovernmentsOther (see NOFO for details)County GovernmentsSpecial District GovernmentsState Governments

Funding Details

Total Program Funding
$450.0M
Expected Number of Awards
60
Cost Sharing Required?
No
Funding Instrument
cooperative_agreement

Key Dates

Posted: June 9, 2026
Application Deadline: TBD (0 days remaining)

Agency Contact

Clarisse Tsang 404-718-5360

mix4@cdc.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov